Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Jan 16, 2020 9:19am
180 Views
Post# 30559605

RE:RE:RE:RE:RE:RE:Former Theralase Director of Investor Relations Guilty

RE:RE:RE:RE:RE:RE:Former Theralase Director of Investor Relations GuiltyTORONTO — A dozen individuals have been ordered to pay thousands of dollars in damages for defamatory statements they made in an internet chat forum, even though the plaintiffs don’t know who they are and collecting will likely prove difficult.
 
The judgment in Ontario Superior Court of Justice comes despite the difficulties in suing people who post inflammatory comments anonymously, and who then fail to respond to the resulting legal proceedings against them.
 
What it does make clear, however, is that anonymity and failure to respond do not necessarily preclude a case from proceeding, or a court from awarding damages.
 
“If people want to make hurtful statements about others and then try to hide from the responsibility to prove the truth or other justification for doing so … their cowardice is reprehensible,” Justice Frederick Myers said in his judgment released Monday.
 
The defamatory comments were posted in 2014 and 2015 on the investor-oriented Bullboard message forum on the website stockhouse.com. They were directed at Toronto-based Theralase Technologies Inc., a publicly traded pharmaceutical company, and its principals, Roger Dumoulin-White and spouse, Kristina Hachey.
 
 
Bullboard Posts